To print this article, all you need is to be registered or login on Mondaq.com.
In the U.S., a prosecution history of a patent (i.e., the
proceedings between the patent applicant and the USPTO from
application filing to patent issuance) comes into play in the
context of claim construction (for example, before a district
court, before the PTAB in a post-grant proceeding, or in the eyes
of a third party analyzing the patent for freedom to operate
reasons), and also in the context of an assessment of infringement
under the doctrine of equivalents. The Federal Circuit has
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global disposable syringes market size is expected to reach USD 12.13 Billion in 2028, and register a CAGR of 5.3% during the forecast period.
Increasing prevalence of various chronic diseases, increasing use of botox injections, and high adoption of injectable drugs are key factors driving market revenue growth.
High preference for administering injectable formulations among doctors in case of emergency or for quicker recovery of patients.
Market growth can be attributed to major factors such as growing geriatric population, preference for injections over drugs over faster recovery, development of technologically advanced syringes, and need for vaccination and immunization programs globally.
Monday, May 10, 2021
In the U.S., a prosecution history of a patent (i.e., the proceedings between the patent applicant and the USPTO from application filing to patent issuance) comes into play in the context of claim construction (for example, before a district court, before the PTAB in a post-grant proceeding, or in the eyes of a third party analyzing the patent for freedom to operate reasons), and also in the context of an assessment of infringement under the doctrine of equivalents. The Federal Circuit has recognized distinct roles of the prosecution history in claim construction and infringement under the doctrine of equivalents:
Share this article
Share this article
ResearchAndMarkets.com s offering.
At an estimated value of over USD 6.78 billion in 2019, the Global Smart Syringes Market is predicted to thrive at a CAGR of 7.9% and valued at over USD 15.65 billion over the forecast year 2020-2030.
Smart syringes are medical devices designed with safety mechanisms to avoid the reuse of syringes and regulate the unsafe injection practices. These syringes are equipped with its own read/write chip containing preset parameters, ranges, and usage tracking.
It also prevents needlestick injuries to the patient and helps in minimizing transmission of blood-borne diseases such as hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). These syringes are used in various applications including drug delivery, vaccination, and blood specimen collection.
Smart Syringes Market to Witness Massive growth ahead | Becton, Dickinson and Co , Medtronic Plc, Terumo Medical Corporation sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.